Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Completed · Phase 4

Conditions studied: Urinary Incontinence

In brief

This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.

Key facts

Study ID
NCT00127270
Run by
Novartis
People needed
395
Starts
2005-05-01
Expected to finish
2006-02-01
Last updated by the study team
2008-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.